US-EU Index & Corporate Actions Analyst, ORTEX

Harry Kalfas

US-EU Index & Corporate Actions Analyst

Global Financial Data and Analytics Platform

ORTEX

ORTEX is a global financial data and analytics platform providing real-time securities lending and short interest data, index rebalance data, holdings and insider transactions, trading signals, corporate actions and news,  stock machine learning and factor scores and other analytics. The majority of the data are downloadable and accessible through APIs.

Index Rebalance

Beazley is a British multinational specialist insurance and reinsurance company. It underwrites complex and specialist risks across diverse sectors such as cyber, marine, aviation, property, political risks, contingency, and professional liability. The company is headquartered in London, England, and was founded in 1986.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/zurich-insurance-group-ag-6200ef7e-59a6-4d82-87df-6dfcaec68274" target="_blank" data-smartkarma-citation="entities:27910:1" rel="noopener">Zurich Insurance Group (ZURN SW)</a> has agreed to acquire <a href="https://www.smartkarma.com/entities/beazley-plc" target="_blank" data-smartkarma-citation="entities:21835:1" rel="noopener">Beazley (BEZ LN)</a> in an all-cash transaction, with Beazley shareholders receiving 1,310 pence per share.</li>
<li>Nuveen has agreed to acquire <a href="https://www.smartkarma.com/entities/schroders-plc" target="_blank" data-smartkarma-citation="entities:22134:1" rel="noopener">Schroders (SDR LN)</a> in an all-cash transaction, with the two deals expected to become effective at the same time on October 1, 2026.</li>
<li>BEZ and SDR will be removed from UK and European indices, with significant passive demand expected for their intra-quarter replacements in UK Top 100 and Europe Top 600.</li>
</ul>



Zurich Insurance Group (ZURN SW) has agreed to acquire Beazley (BEZ LN) in an all-cash transaction, with Beazley shareholders receiving 1,310 pence per share.
Nuveen has agreed to acquire Schroders (SDR LN) in an all-cash transaction, with the two deals expected to become effective at the same time on October 1, 2026.
BEZ and SDR will be removed from UK and European indices, with significant passive demand expected for their intra-quarter replacements in UK Top 100 and Europe Top 600.


Zurich-Beazley and Nuveen-Schroders Deals Near Completion, UK & European Index Replacements Ahead

Akzo Nobel N.V. manufactures specialty chemicals. The Company offers decorative paints and coatings, surfactants, polymer, pulp and paper, bleaching and oxidizing, salt-chlorine, and other chemical products. Akzo Nobel serves customers worldwide.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/akzo-nobel-nv" target="_blank" data-smartkarma-citation="entities:21093:1" rel="noopener">Akzo Nobel NV (AKZA NA)</a> and <a href="https://www.smartkarma.com/entities/axalta-coating-systems-ltd" target="_blank" data-smartkarma-citation="entities:8278:1" rel="noopener">Axalta Coating Systems (AXTA US)</a> will merge in a cross-border all-stock merger of equals.</li>
<li>The transaction is expected to close later in late 2026 to early 2027 (subject to approvals) with AXTA shareholders receiving 0.6539 AKZA shares per AXTA share.</li>
<li>Upon completion, the deal will trigger significant passive inflows, with an upweight of <a href="https://www.smartkarma.com/entities/akzo-nobel-nv" target="_blank" data-smartkarma-citation="entities:21093:1" rel="noopener">Akzo Nobel NV (AKZA NA)</a> and the removal of <a href="https://www.smartkarma.com/entities/axalta-coating-systems-ltd" target="_blank" data-smartkarma-citation="entities:8278:1" rel="noopener">Axalta Coating Systems (AXTA US)</a> from relevant indices.</li>
</ul>



Akzo Nobel NV (AKZA NA) and Axalta Coating Systems (AXTA US) will merge in a cross-border all-stock merger of equals.
The transaction is expected to close later in late 2026 to early 2027 (subject to approvals) with AXTA shareholders receiving 0.6539 AKZA shares per AXTA share.
Upon completion, the deal will trigger significant passive inflows, with an upweight of Akzo Nobel NV (AKZA NA) and the removal of Axalta Coating Systems (AXTA US) from relevant indices.


Cross-Border Merger of Akzo Nobel and Axalta Creating $25B Group: Big US and EU Index Flows Expected

Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/boston-scientific-corp-7b5acbaf-edc4-4649-ac81-c71e7328f7bb" target="_blank" data-smartkarma-citation="entities:26842:1" rel="noopener">Boston Scientific (BSX UN)</a> is acquiring <a href="https://www.smartkarma.com/entities/penumbra-inc" target="_blank" data-smartkarma-citation="entities:26380:1" rel="noopener">Penumbra (PEN US)</a> in a cash-or-stock transaction valued at approximately $14.5B.</li>
<li>The transaction is expected to close later in 2026 (subject to approvals) with PEN shareholders receiving either $374 in cash or 3.8721 BSX shares per PEN share.</li>
<li>Upon completion, the deal will trigger significant passive inflows, with an upweight of <a href="https://www.smartkarma.com/entities/boston-scientific-corp-7b5acbaf-edc4-4649-ac81-c71e7328f7bb" target="_blank" data-smartkarma-citation="entities:26842:1" rel="noopener">Boston Scientific (BSX UN)</a> and the removal of <a href="https://www.smartkarma.com/entities/penumbra-inc" target="_blank" data-smartkarma-citation="entities:26380:1" rel="noopener">Penumbra (PEN US)</a> from relevant indices.</li>
</ul>



Boston Scientific (BSX UN) is acquiring Penumbra (PEN US) in a cash-or-stock transaction valued at approximately $14.5B.
The transaction is expected to close later in 2026 (subject to approvals) with PEN shareholders receiving either $374 in cash or 3.8721 BSX shares per PEN share.
Upon completion, the deal will trigger significant passive inflows, with an upweight of Boston Scientific (BSX UN) and the removal of Penumbra (PEN US) from relevant indices.


Boston Scientific to Acquire Penumbra: $14.5B Deal Triggering Significant Index Flows

Aptiv PLC manufactures vehicle components. The Company produces electronic safety for automobile and commercial vehicle manufacturers. Aptiv supplies original equipment manufacturers throughout the world.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/delphi-automotive-plc" target="_blank" data-smartkarma-citation="entities:20870:1" rel="noopener">Aptiv PLC (APTV US)</a> is spinning off its Electrical Distribution Systems business into a standalone publicly listed company, Versigent (VGNT US).</li>
<li>Versigent is expected to list on the New York Stock Exchange on April 1, 2026 under the ticker “VGNT”.</li>
<li>The transaction is expected to trigger index implications across U.S. and global indices, effective on an intra-quarter basis.</li>
</ul>



Aptiv PLC (APTV US) is spinning off its Electrical Distribution Systems business into a standalone publicly listed company, Versigent (VGNT US).
Versigent is expected to list on the New York Stock Exchange on April 1, 2026 under the ticker “VGNT”.
The transaction is expected to trigger index implications across U.S. and global indices, effective on an intra-quarter basis.


Aptiv Spins Off Versigent: US and Global Index Implications Triggered

JDE Peet's N.V. produces and supplies coffee and tea beverages. The Company markets its products and solutions through a go-to-market approach across the CPG, out of home, retail, and online sales channels. JDE Peet's serves customers worldwide.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/keurig-dr-pepper-inc" target="_blank" data-smartkarma-citation="entities:15411:1" rel="noopener">Keurig Dr Pepper (KDP US)</a> has launched an all-cash tender offer to acquire JDE Peet's N.V. (JDEP NA), with JDE Peet’s shareholders entitled to €31.85 per share.</li>
<li>The tender offer is open from 16 January 2026 to 27 March 2026, unless extended.</li>
<li>Upon completion, JDE Peet's N.V. (JDEP NA) will be removed from European and Global indices.</li>
</ul>



Keurig Dr Pepper (KDP US) has launched an all-cash tender offer to acquire JDE Peet's N.V. (JDEP NA), with JDE Peet’s shareholders entitled to €31.85 per share.
The tender offer is open from 16 January 2026 to 27 March 2026, unless extended.
Upon completion, JDE Peet's N.V. (JDEP NA) will be removed from European and Global indices.


Keurig Dr Pepper’s €15.7B Deal for JDE Peet’s - Index Changes and a New Chapter for Coffee Strategy

Index Rebalance professional with expertise in assessing the impact of Corporate Actions on major U.S., EU, and global indices. Specialized in forecasting index adjustments driven by Mergers & Acquisitions, Spin-offs, IPOs, and Equity Offerings, as well as analyzing shareholder structures and calculating free float. Assessed capital flows and capital invested in major equity indices. All forecasts and analyses are derived from publicly available, reliable sources, including exchange filings, regulatory disclosures, company announcements, and ETFs, without the use of index data. Producing forecasts for both scheduled and unscheduled index rebalances while providing insights into key aspects of Corporate Actions throughout their lifecycle.

Harry Kalfas
US-EU Index & Corporate Actions Analyst
• ORTEX

Zurich-Beazley and Nuveen-Schroders Deals Near Completion, UK & European Index Replacements Ahead

Zurich-Beazley and Nuveen-Schroders deals trigger UK and European index removals, creating significant passive demand for the intra-quarter...

Harry Kalfas

Cross-Border Merger of Akzo Nobel and Axalta Creating $25B Group: Big US and EU Index Flows Expected

Akzo Nobel NV (AKZA NA) and Axalta Coating Systems (AXTA US) are merging in a $25B cross-border all-stock merger of equals, expected to trigger...

Harry Kalfas

Boston Scientific to Acquire Penumbra: $14.5B Deal Triggering Significant Index Flows

Boston Scientific’s (BSX) $14.5B cash-or-stock acquisition of Penumbra (PEN US) will drive passive flows, leading to the upweight of BSX and...

Harry Kalfas

Aptiv Spins Off Versigent: US and Global Index Implications Triggered

Aptiv PLC (APTV US) is spinning off Versigent (VGNT US), which will list on the NYSE on 1 April 2026 with 17 March as the record date, triggering...

Harry Kalfas

Keurig Dr Pepper’s €15.7B Deal for JDE Peet’s - Index Changes and a New Chapter for Coffee Strategy

Keurig Dr Pepper launches €15.7 B all-cash tender offer for JDE Peet’s, reshaping its coffee strategy and prompting potential index adjustments.

Harry Kalfas

Zurich-Beazley and Nuveen-Schroders Deals Near Completion, UK & European Index Replacements Ahead

Zurich-Beazley and Nuveen-Schroders deals trigger UK and European index removals, creating significant passive demand for the intra-quarter...

Harry Kalfas

Cross-Border Merger of Akzo Nobel and Axalta Creating $25B Group: Big US and EU Index Flows Expected

Akzo Nobel NV (AKZA NA) and Axalta Coating Systems (AXTA US) are merging in a $25B cross-border all-stock merger of equals, expected to trigger...

Harry Kalfas

Boston Scientific to Acquire Penumbra: $14.5B Deal Triggering Significant Index Flows

Boston Scientific’s (BSX) $14.5B cash-or-stock acquisition of Penumbra (PEN US) will drive passive flows, leading to the upweight of BSX and...

Harry Kalfas

Aptiv Spins Off Versigent: US and Global Index Implications Triggered

Aptiv PLC (APTV US) is spinning off Versigent (VGNT US), which will list on the NYSE on 1 April 2026 with 17 March as the record date, triggering...

Harry Kalfas

Keurig Dr Pepper’s €15.7B Deal for JDE Peet’s - Index Changes and a New Chapter for Coffee Strategy

Keurig Dr Pepper launches €15.7 B all-cash tender offer for JDE Peet’s, reshaping its coffee strategy and prompting potential index adjustments.

Harry Kalfas

Keurig Dr Pepper launches €15.7 B all-cash tender offer for JDE Peet’s, reshaping its coffee strategy and prompting potential index adjustments.